Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Fate Therapeutics, Inc. reported new employee inducement awards under Nasdaq Listing Rule 5635(c)(4). The company is focused on developing induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for cancer and autoimmune diseases.
Fate Therapeutics said it granted new employee inducement awards under Nasdaq Listing Rule 5635(c)(4).
Fate Therapeutics grants new employee inducement awards